BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,843,000 | -11.8% | 26,374 | -74.3% | 1.18% | -34.4% |
| Q1 2022 | $4,359,000 | -60.6% | 102,497 | +27.6% | 1.80% | -59.8% |
| Q4 2021 | $11,073,000 | +28.8% | 80,348 | +29.8% | 4.49% | -7.7% |
| Q3 2021 | $8,598,000 | +56.4% | 61,897 | +9.3% | 4.86% | +98.2% |
| Q2 2021 | $5,497,000 | +60.5% | 56,626 | +13.1% | 2.45% | +31.3% |
| Q1 2021 | $3,424,000 | +142.1% | 50,089 | +203.6% | 1.87% | +127.3% |
| Q4 2020 | $1,414,000 | – | 16,500 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |